Nalaganje...
Seamless Phase I/II Adaptive Design For Oncology Trials of Molecularly Targeted Agents
In dose-finding trials of chemotherapeutic agents, the goal of identifying the maximum tolerated dose is usually determined by considering information on toxicity only, with the assumption that the highest safe dose also provides the most promising outlook for efficacy. Trials of molecularly targete...
Shranjeno v:
| izdano v: | J Biopharm Stat |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4363077/ https://ncbi.nlm.nih.gov/pubmed/24904956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2014.920873 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|